Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Clinical trial NCT07524452 · RECRUITING

Trial details

NCT number: NCT07524452
Sponsor: Ming-Yuan Chen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Head and Neck Squamous Cell Carcinoma

Start date: 2026-02-06
Primary completion: 2031-02-28
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.